Contineum Therapeutics
CTNM
#6725
Rank
$0.47 B
Marketcap
$18.40
Share price
-0.81%
Change (1 day)
N/A
Change (1 year)

Contineum Therapeutics (CTNM) - P/B ratio

P/B ratio as of November 2024 : 2.18

According to Contineum Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Contineum Therapeutics - P/B ratio (from 2024 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A
2023-12-31N/A
2022-12-31N/A